• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ENDOLOGIX SANTA ROSA OVATION IX; MAIN BODY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ENDOLOGIX SANTA ROSA OVATION IX; MAIN BODY Back to Search Results
Model Number TV-AB2980-J
Medical Device Problem Codes Use of Device Problem (1670); Device-Device Incompatibility (2919); Insufficient Device Problem Information (3190)
Health Effect - Clinical Code Failure of Implant (1924)
Date of Event 06/23/2020
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
The device involved in this event will not be returned for evaluation as it remains implanted in the patient.Patient medical records and imaging studies will be requested for further evaluation by the clinical specialist.If additional information pertinent to the incident is obtained, a follow-up report will be submitted.
 
Event or Problem Description
The patient was initially implanted with the ovation ix abdominal stent graft system to treat an abdominal aortic aneurysm (aaa).Approximately (1) month post initial procedure, a routine follow up ct (computed tomography) identified a type 1a endoleak.The patient is currently stable and is being monitored.
 
Additional Manufacturer Narrative
An evaluation of the manufacturing record was completed.A review of the part number/lot number combination needed for device identification shows the device to have been properly manufactured and released in accordance with the device master record.The review confirms there were no manufacturing or processing non-conformities identified that would contribute to the reported adverse event/incident.There are no other equivalent adverse events/incidents for this lot number existing within the endologix complaint handling system.An evaluation of the device could not be completed.The device was not returned to endologix for evaluation because it remains implanted.A clinical evaluation of the adverse event was completed.An examination of medical records and/or medical imaging received by endologix shows that the type 1a endoleak complaint is confirmed.The most likely causation for type 1a endoleak user relates due to the off label - concomitant use with products outside the ifu.Non- endologix stents were identified to be implanted in the aorta and iliac arteries at the initial procedure.The final patient status was reported being under surveillance.No additional investigation of this reported adverse event/incident is planned.However, should additional information relevant to the investigation outcome become available, a follow-up report will be submitted.Endologix will continue to monitor this and similar adverse events/incidents.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OVATION IX
Common Device Name
MAIN BODY
Manufacturer (Section D)
ENDOLOGIX SANTA ROSA
3910 brickway blvd
santa rosa CA 95403
MDR Report Key10306264
Report Number3008011247-2020-00078
Device Sequence Number13654290
Product Code MIH
UDI-Device IdentifierM701TVAB2980J1
UDI-Public+M701TVAB2980J1/$$3221121FS111919177
Combination Product (Y/N)N
Initial Reporter StateOK
PMA/510(K) Number
P120006
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2020
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Physician
Remedial Action Other
Type of Report Initial,Followup
Report Date (Section B) 06/23/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date11/21/2022
Device Model NumberTV-AB2980-J
Device Catalogue NumberTV-AB2980-J
Device Lot NumberFS111919-17
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer 06/23/2020
Supplement Date Received by Manufacturer06/23/2020
Initial Report FDA Received Date07/22/2020
Supplement Report FDA Received Date09/14/2020
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
ILIAC LIMB, LOT FS031320-12; ILIAC LIMB, LOT FS032620-36; ILIAC LIMB, LOT FS101619-09; ILIAC LIMB, LOT FS120619-16; POLYMER, LOT FF021120-01; ILIAC LIMB, LOT FS031320-12; ILIAC LIMB, LOT FS032620-36; ILIAC LIMB, LOT FS101619-09; ILIAC LIMB, LOT FS120619-16; POLYMER, LOT FF021120-01
Outcome Attributed to Adverse Event Other;
Patient Age81 YR
-
-